COMPARISON OF BIPARAMETRIC AND MULTIPARAMETRIC MRI IN DIAGNOSIS OF PROSTATE CANCER

Thanh Dũng Lê1,2,, Duy Hùng Nguyễn3, Thị Hải Anh Nguyễn3
1 Viet Duc hospital
2 VNU Hanoi-University of Medicine and Pharmacy
3 Hanoi medical university

Main Article Content

Abstract

Objectives: Compare the reliability and diagnostic performance of prostate cancer of biparametric MRI and multiparametric MRI using the PIRADs 2.1. Methods and subject:  82 patients suspected prostate cancer were underwent multiparametric MRI 3.0T including T2W, DWI, DCE and had histopathological results through biopsy. Lesions were graded 1 to 5 for T2W and DWI sequences, graded negative or positive for DCE according to the PIRADs 2.1, total PIRADs scores for 2 sequences (T2W and DWI), and total PIRADs for 3 sequences (T2W, DWI, DCE). The standard used for comparison is the 12 points biopsy pathology results. Results: Among 82 patients with 328 lesions, there were 159 tumoral lesions and 169 benign lesions. Sensitivity, specificity, positive predictive value, negative predictive value of biparametric MRI were 86.8%; 96,4%; 95,8% 88,6%, respectively. These values of multiparametric MRI were 88.7%; 86,4%; 95,9%; 90%, respectively. Conclusion: When using the PIRADs 2.1, the diagnostic value of biparametric MRI can be considered equivalent to multiparametric MRI in identifying prostate cancer. DCE should be used as an optional sequence, indicated additionally on certain cases.

Article Details

References

1. Muehlematter UJ, Burger IA, Becker AS, et al. Diagnostic Accuracy of Multiparametric MRI versus 68Ga-PSMA-11 PET/MRI for Extracapsular Extension and Seminal Vesicle Invasion in Patients with Prostate Cancer. Radiology. 2019;293(2):350-358. doi:10.1148/radiol.2019190687
2. Turkbey B, Rosenkrantz AB, Haider MA, et al. Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. Eur Urol. 2019;76(3):340-351. doi:10.1016/j.eururo.2019.02.033
3. Gadolinium Deposition and Nephrogenic Systemic Fibrosis: A Radiologist’s Primer | RadioGraphics. Accessed October 17, 2021. https://pubs.rsna.org/doi/10.1148/rg.2020190110
4. Bass EJ, Pantovic A, Connor M, et al. A systematic review and meta-analysis of the diagnostic accuracy of biparametric prostate MRI for prostate cancer in men at risk. Prostate Cancer Prostatic Dis. 2021;24(3):596-611. doi:10.1038/s41391-020-00298-w
5. Woo S, Suh CH, Kim SY, Cho JY, Kim SH, Moon MH. Head-to-Head Comparison Between Biparametric and Multiparametric MRI for the Diagnosis of Prostate Cancer: A Systematic Review and Meta-Analysis. American Journal of Roentgenology. 2018;211(5):W226-W241. doi:10.2214/AJR.18.19880
6. Zeng J, Cheng Q, Zhang D, Fan M, Shi C, Luo L. Diagnostic Ability of Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Prostate Cancer and Clinically Significant Prostate Cancer in Equivocal Lesions: A Systematic Review and Meta-Analysis. Frontiers in Oncology. 2021;11:7. doi:10.3389/fonc.2021.620628
7. Vargas HA, Hötker AM, Goldman DA, et al. Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference. Eur Radiol. 2016;26(6):1606-1612. doi:10.1007/ s00330-015-4015-6
8. Kuhl CK, Bruhn R, Krämer N, Nebelung S, Heidenreich A, Schrading S. Abbreviated Biparametric Prostate MR Imaging in Men with Elevated Prostate-specific Antigen. Radiology. 2017;285(2):493-505. doi:10.1148/radiol.2017170129